Notice Number: NOT-DA-07-017
Release Date: July 18, 2007
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
The National Institute on Drug Abuse (NIDA) requests that investigators researching the genetics of drug addiction who plan to submit applications requesting resources of The Center for Inherited Disease Research (CIDR) to genotype their samples for SNP Genome Wide Association Scans, Whole Genome SNP Linkage Scans, Custom SNP genotyping (Stage 2 of Genome Wide Association Study, Fine Mapping projects, Positional or Functional Candidate Gene studies) submit letters of intent by Sept 4, 2007 if they wish to submit applications to CIDR for the November 1, 2007, March 1, 2008, or July 1, 2008 deadlines.
Letters of intent are being requested by NIDA for purposes of fiscal planning for FY 2008 for those NIDA-associated investigators anticipating request to use CIDR resources in FY 2008. The letter of intent will be used for NIDA’s fiscal planning and does not constitute a commitment of funds from NIDA for the requested use of CIDR resources nor does it provide permission to apply for CIDR genotyping. NIDA as well as other participating NIH Institutes requires prior approval from the institute liaison before an investigator can submit an application to CIDR. The NIDA Institute Liaison is Jonathan D. Pollock, Ph.D.
Prospective applicants are asked to submit a letter of intent that includes the following information:
Direct inquiries regarding this Notice to:
Jonathan D. Pollock, Ph.D.
Genetics and Molecular Neurobiology Research Branch
Division of Basic Neurosicence and Behavioral Research
National Institute on Drug Abuse (NIDA)
Bethesda, MD 20892
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)